Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J K Luce

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Cancer Chemotherapy Reports|February 1, 1971
Phase I and phototoxicity studies of pseudourea (NSC-56054)E Frei, J K Luce, T L Loo
Cancer|March 1, 1972
An evaluation of the management of patients with cerebral metastases from malignant melanomaJ A Gottlieb, E Frei, J K Luce
Cancer Chemotherapy Reports|June 1, 1971
Dose-schedule studies with hydroxyurea (NSC-32065) in malignant melanomaJ A Gottlieb, E Frei, J K Luce
American Journal of Hospital Pharmacy|February 1, 1983
Doxorubicin hydrochloride-aluminum interactionM J Williamson, J K Luce, W K Hausmann
Oncology Nursing Forum|May 1, 1990
Doxorubicin-associated flare reactionsC F Curran, J K Luce, J A Page
The Journal of Clinical Investigation|June 1, 1970
Cell proliferation in human melanomaS Shirakawa, J K Luce, I Tannock, et al.
The Journal of Urology|March 1, 1972
Histiocytic reticulum cell sarcoma presenting as a testicular tumorD E Johnson, J J Butler, J K Luce
Cancer Research|February 1, 1970
L-asparagine requirement and the effect of L-asparaginase on the normal and leukemic human bone marrowD H Ho, J P Whitecar, J K Luce, et al.
Cancer Research|April 1, 1973
Bleomycin as a possible synchronizing agent for human tumor cells in vivoS C Barranco, J K Luce, M M Romsdahl, et al.
Cancer Chemotherapy Reports|April 1, 1970
Clinical trials with the antitumor agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide(NSC-45388)J K Luce, W G Thurman, B L Isaacs, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Cancer Chemotherapy Reports|February 1, 1971
Phase I and phototoxicity studies of pseudourea (NSC-56054)E Frei, J K Luce, T L Loo
Cancer|March 1, 1972
An evaluation of the management of patients with cerebral metastases from malignant melanomaJ A Gottlieb, E Frei, J K Luce
Cancer Chemotherapy Reports|June 1, 1971
Dose-schedule studies with hydroxyurea (NSC-32065) in malignant melanomaJ A Gottlieb, E Frei, J K Luce
American Journal of Hospital Pharmacy|February 1, 1983
Doxorubicin hydrochloride-aluminum interactionM J Williamson, J K Luce, W K Hausmann
Oncology Nursing Forum|May 1, 1990
Doxorubicin-associated flare reactionsC F Curran, J K Luce, J A Page
The Journal of Clinical Investigation|June 1, 1970
Cell proliferation in human melanomaS Shirakawa, J K Luce, I Tannock, et al.
The Journal of Urology|March 1, 1972
Histiocytic reticulum cell sarcoma presenting as a testicular tumorD E Johnson, J J Butler, J K Luce
Cancer Research|February 1, 1970
L-asparagine requirement and the effect of L-asparaginase on the normal and leukemic human bone marrowD H Ho, J P Whitecar, J K Luce, et al.
Cancer Research|April 1, 1973
Bleomycin as a possible synchronizing agent for human tumor cells in vivoS C Barranco, J K Luce, M M Romsdahl, et al.
Cancer Chemotherapy Reports|April 1, 1970
Clinical trials with the antitumor agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide(NSC-45388)J K Luce, W G Thurman, B L Isaacs, et al.
Pageof 5